Boardroom Alpha
Start trial
10-K primary document
SGHT · Annual Report (Form 10-K) · Filed March 4, 2026

Sight Sciences Inc — 10-K exhibit

sght-ex24_1.htm
Sight Sciences Inc on Boardroom Alpha
EX-24.1

 

Exhibit 24.1

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Paul Badawi and James Rodberg, and each of them individually, his and her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and her and in his and her name, place, and stead, in any and all capacities, to sign any and all amendments to this Report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

 

Name and Signature

Title

Date

/s/ Paul Badawi

President, Chief Executive Officer and Director

March 4, 2026

Paul Badawi

(Principal Executive Officer)

 

 

/s/ James Rodberg

Chief Financial Officer (Principal Financial

March 4, 2026

James Rodberg

and Accounting Officer)

 

 

/s/ Staffan Encrantz

Chairman of the Board of Directors

March 4, 2026

Staffan Encrantz

 

 

/s/ David Badawi

 Chief Technology Officer and Director

March 4, 2026

David Badawi, M.D.

 

 

/s/ Tamara Fountain

 Director

March 4, 2026

Tamara Fountain, M.D.

 

 

/s/ Gerhard Burbach

 Director

March 4, 2026

Gerhard Burbach

 

 

/s/ Catherine Mazzacco

 Director

March 4, 2026

Catherine Mazzacco

 

 

/s/ Donald Zurbay

 Director

March 4, 2026

Donald Zurbay

 

 

 

 

 

 

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer